- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Hepatic Oxygenation Changes and Symptomatic Intradialytic Hypotension ; volume:49 ; number:1 ; year:2024 ; pages:368-376 ; extent:9
Kidney & blood pressure research ; 49, Heft 1 (2024), 368-376 (gesamt 9)
- Creator
-
Ookawara, Susumu
Ito, Kiyonori
Sasabuchi, Yusuke
Ueda, Yuichiro
Morino, Junki
Kaneko, Shohei
Mutsuyoshi, Yuko
Kitano, Taisuke
Hirai, Keiji
Morishita, Yoshiyuki
- DOI
-
10.1159/000539277
- URN
-
urn:nbn:de:101:1-2412260141448.527925482362
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ookawara, Susumu
- Ito, Kiyonori
- Sasabuchi, Yusuke
- Ueda, Yuichiro
- Morino, Junki
- Kaneko, Shohei
- Mutsuyoshi, Yuko
- Kitano, Taisuke
- Hirai, Keiji
- Morishita, Yoshiyuki
Other Objects (12)
Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
LAMS for symptomatic hepatic cysts: beyond the boundary
Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
Foam Sclerotherapy for a Symptomatic Hepatic Cyst: A Preliminary Report
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Orthostatic hypotension
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Endovascular treatment of symptomatic hepatic venous outflow obstruction post major liver resection
Visualizing regional myocardial oxygenation changes with statistically optimal colormaps
Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
LAMS for symptomatic hepatic cysts: beyond the boundary
Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
Foam Sclerotherapy for a Symptomatic Hepatic Cyst: A Preliminary Report
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Orthostatic hypotension
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Endovascular treatment of symptomatic hepatic venous outflow obstruction post major liver resection
Visualizing regional myocardial oxygenation changes with statistically optimal colormaps
Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
LAMS for symptomatic hepatic cysts: beyond the boundary
Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
Foam Sclerotherapy for a Symptomatic Hepatic Cyst: A Preliminary Report
Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Orthostatic hypotension
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Endovascular treatment of symptomatic hepatic venous outflow obstruction post major liver resection
Visualizing regional myocardial oxygenation changes with statistically optimal colormaps